The global home dialysis systems market size was estimated to be USD 22.54 billion in 2023 and is expected to reach at USD 66.60 billion by 2034 with a CAGR of 10.35% during the forecast period 2024-2034. The industry is experiencing advancements in technology, an increase in the risks linked to transplants, a rise in the prevalence of chronic kidney diseases, initiatives by key players to introduce advanced products and services, a shortage of organ donors, a higher number of diabetic and hypertension patients, a growing elderly population, increased government investments, and a rise in regulatory approvals for advanced home dialysis systems are some of the key factors boosting the market growth.
A rise in regulatory approvals for advanced home dialysis systems is predicted to boost the market growth during the forecast period. Home dialysis enables individuals with chronic kidney disease to conduct dialysis treatments in the convenience of their residences. This process employs a dialysis machine and a specific filter known as an artificial kidney or dialyzer to eliminate waste and excess fluid from the bloodstream. Home dialysis efficiently manages essential blood minerals such as potassium, salt, and calcium, in addition to regulating blood pressure. For instance, in August 2023, The FDA in the United States has granted 510(k) clearance for VersiHD with GuideMe Software to Fresenius Medical Care, a prominent global provider of goods and services for people with kidney illnesses. This represents a complete redesign of the self-guided interface for Fresenius Medical Care's VersiHD chronic home hemodialysis (HHD) system.
By type, hemodialysis (HD) was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increasing acceptance of advanced products for chronic kidney diseases, a rising occurrence of acute kidney injury, a surge in technological advancements, and a growing number of launches of innovative products. For instance, in November 2023, Diality Inc. has revealed plans to debut its Moda-flx Hemodialysis System during ASN Kidney Week 2023, scheduled for November 1-5 at the Pennsylvania Convention Center in Philadelphia. Additionally, peritoneal dialysis (PD) is predicted to grow at the fastest CAGR during the forecast period owing to the major market players are prioritizing the introduction of innovative products, with increasing approvals from regulatory bodies. Various companies are providing systems and consumables specifically designed for continuous peritoneal dialysis and automated peritoneal dialysis for home use.
By product, service was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increase in the number of providers offering dialysis services, a rise in the prevalence of End-Stage Renal Disease (ESRD), continuous technological advancements, and a surge in initiatives undertaken by various manufacturers in the field. Additionally, consumables is predicted to grow at the fastest CAGR during the forecast period owing to the governments are increasingly investing in initiatives aimed at enhancing patient safety, promoting patient-centered care, & improving overall efficacy, a rising demand for catheters coated with antimicrobial agents to mitigate the risk of bloodstream infections, and regulatory bodies are increasingly approving such innovations. For instance, in August 2023, Quanta Dialysis Technologies has disclosed that it obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for broadening the indication of the Quanta Dialysis System. This compact and user-friendly hemodialysis device is now approved for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF).
By treatment, chronic kidney disease was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increasing prevalence of chronic diseases like high blood pressure and diabetes, a growing aging population, and continuous technological advancements in the healthcare sector. Additionally, acute kidney disease is predicted to grow at the fastest CAGR during the forecast period owing to the geriatric population is on the rise, leading to increased adoption of advanced acute kidney injury equipment and diagnostic treatments, and surge in collaborations among market players. For instance, in September 2022, Terumo Corporation has disclosed that WEGO Terumo (Weihai) Medical Products CO., Ltd, a China-based joint venture between medical device firm WEGO and Terumo, has secured regulatory clearance from the National Medical Products Administration (NMPA) to produce and commercialize an innovative neutral peritoneal dialysis solution.
North America region is anticipated for the highest revenue share during the forecast period owing to the involvement of key participants, a conducive reimbursement environment, an increasing occurrence of chronic kidney diseases (CKD), and substantial government investments in the development of innovative medical devices. For instance, in February 2023, The National Kidney Foundation (NKF) has disclosed the recent investment from its Innovation Fund, a philanthropic impact investment program. Relavo, a company founded by women with a focus on improving accessibility to home dialysis, will be the recipient of this investment. The funding aims to support the further development of Relavo's PeritoneX technology, with the goal of enhancing the safety of peritoneal dialysis (PD) for patients. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing elderly population, a rise in the occurrence of kidney failure, the accelerated development of advanced products, heightened awareness campaigns regarding chronic kidney disease (CKD), the establishment of newly-equipped, state-of-the-art healthcare facilities, and a growing introduction of advanced solutions. For instance, in April 2023, Medtronic plc and DaVita Inc have introduced Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions.
A rise in regulatory approvals for advanced home dialysis systems is predicted to boost the market growth during the forecast period. Home dialysis enables individuals with chronic kidney disease to conduct dialysis treatments in the convenience of their residences. This process employs a dialysis machine and a specific filter known as an artificial kidney or dialyzer to eliminate waste and excess fluid from the bloodstream. Home dialysis efficiently manages essential blood minerals such as potassium, salt, and calcium, in addition to regulating blood pressure. For instance, in August 2023, The FDA in the United States has granted 510(k) clearance for VersiHD with GuideMe Software to Fresenius Medical Care, a prominent global provider of goods and services for people with kidney illnesses. This represents a complete redesign of the self-guided interface for Fresenius Medical Care's VersiHD chronic home hemodialysis (HHD) system.
By type, hemodialysis (HD) was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increasing acceptance of advanced products for chronic kidney diseases, a rising occurrence of acute kidney injury, a surge in technological advancements, and a growing number of launches of innovative products. For instance, in November 2023, Diality Inc. has revealed plans to debut its Moda-flx Hemodialysis System during ASN Kidney Week 2023, scheduled for November 1-5 at the Pennsylvania Convention Center in Philadelphia. Additionally, peritoneal dialysis (PD) is predicted to grow at the fastest CAGR during the forecast period owing to the major market players are prioritizing the introduction of innovative products, with increasing approvals from regulatory bodies. Various companies are providing systems and consumables specifically designed for continuous peritoneal dialysis and automated peritoneal dialysis for home use.
By product, service was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increase in the number of providers offering dialysis services, a rise in the prevalence of End-Stage Renal Disease (ESRD), continuous technological advancements, and a surge in initiatives undertaken by various manufacturers in the field. Additionally, consumables is predicted to grow at the fastest CAGR during the forecast period owing to the governments are increasingly investing in initiatives aimed at enhancing patient safety, promoting patient-centered care, & improving overall efficacy, a rising demand for catheters coated with antimicrobial agents to mitigate the risk of bloodstream infections, and regulatory bodies are increasingly approving such innovations. For instance, in August 2023, Quanta Dialysis Technologies has disclosed that it obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) for broadening the indication of the Quanta Dialysis System. This compact and user-friendly hemodialysis device is now approved for two modalities of continuous renal replacement therapy (CRRT): continuous venovenous hemodialysis (CVVHD) and slow continuous ultrafiltration (SCUF).
By treatment, chronic kidney disease was the highest revenue-grossing segment in the global home dialysis systems market in 2023 owing to the increasing prevalence of chronic diseases like high blood pressure and diabetes, a growing aging population, and continuous technological advancements in the healthcare sector. Additionally, acute kidney disease is predicted to grow at the fastest CAGR during the forecast period owing to the geriatric population is on the rise, leading to increased adoption of advanced acute kidney injury equipment and diagnostic treatments, and surge in collaborations among market players. For instance, in September 2022, Terumo Corporation has disclosed that WEGO Terumo (Weihai) Medical Products CO., Ltd, a China-based joint venture between medical device firm WEGO and Terumo, has secured regulatory clearance from the National Medical Products Administration (NMPA) to produce and commercialize an innovative neutral peritoneal dialysis solution.
North America region is anticipated for the highest revenue share during the forecast period owing to the involvement of key participants, a conducive reimbursement environment, an increasing occurrence of chronic kidney diseases (CKD), and substantial government investments in the development of innovative medical devices. For instance, in February 2023, The National Kidney Foundation (NKF) has disclosed the recent investment from its Innovation Fund, a philanthropic impact investment program. Relavo, a company founded by women with a focus on improving accessibility to home dialysis, will be the recipient of this investment. The funding aims to support the further development of Relavo's PeritoneX technology, with the goal of enhancing the safety of peritoneal dialysis (PD) for patients. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing elderly population, a rise in the occurrence of kidney failure, the accelerated development of advanced products, heightened awareness campaigns regarding chronic kidney disease (CKD), the establishment of newly-equipped, state-of-the-art healthcare facilities, and a growing introduction of advanced solutions. For instance, in April 2023, Medtronic plc and DaVita Inc have introduced Mozarc Medical, an independent company dedicated to transforming kidney health and advancing patient-centered technology solutions.
Segmentation: Home Dialysis Systems Market Report 2023 - 2034
Home Dialysis Systems Market Analysis & Forecast by Type 2023 - 2034 (Revenue USD Bn)
- Peritoneal Dialysis
- Ambulatory Peritoneal Dialysis (APD)
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Hemodialysis
- Conventional
- Nocturnal Hemodialysis
- Short Daily Hemodialysis
Home Dialysis Systems Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Service
- Consumables
- Concentrates
- Bloodlines
- Catheters
- Others
- Device
- Dialyzers
- Machine
- Water Treatment System
- Others
Home Dialysis Systems Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)
- Chronic Kidney Disease
- Acute Kidney Disease
Home Dialysis Systems Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Home Dialysis Systems Market: Type Estimates & Trend Analysis
8. Home Dialysis Systems Market: Product Estimates & Trend Analysis
9. Home Dialysis Systems Market: Treatment Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Home Dialysis Systems Market
12. Europe Global Home Dialysis Systems Market
13. Asia Pacific Global Home Dialysis Systems Market
14. Latin America Global Home Dialysis Systems Market
15. MEA Global Home Dialysis Systems Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Quanta Dialysis Technologies
- Cantel Medical.
- B Fresenius Medical Care
- DaVita.
- Baxter International Inc.
- Outset Medical
- Europlaz Technologies Ltd
- AWAK Technologies
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 22.54 Billion |
| Forecasted Market Value ( USD | $ 66.6 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
